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Abstract:  Polyphenols, including flavonoids, phenolic acids, proanthocyanidins and 
resveratrol, are a large and heterogeneous group of phytochemicals in plant-based foods, 
such as tea, coffee, wine, cocoa, cereal grains, soy, fruits and berries. Growing evidence 
indicates that various dietary polyphenols may influence carbohydrate metabolism at many 
levels. In animal models and a limited number of human studies carried out so far, 
polyphenols and foods or beverages rich in polyphenols have attenuated postprandial 
glycemic responses and fasting hyperglycemia, and improved acute insulin secretion and 
insulin sensitivity. The possible mechanisms include inhibition of carbohydrate digestion 
and glucose absorption in the intestine, stimulation of insulin secretion from the pancreatic 
cells, modulation of glucose release from the liver, activation of insulin receptors and 
glucose uptake in the insulin-sensitive tissues, and modulation of intracellular signalling 
pathways and gene expression. The positive effects of polyphenols on glucose homeostasis 
observed in a large number of in vitro and animal models are supported by epidemiological 
evidence on polyphenol-rich diets. To confirm the implications of polyphenol consumption 
for prevention of insulin resistance, metabolic syndrome and eventually type 2 diabetes, 
human trials with well-defined diets, controlled study designs and clinically relevant end-
points together with holistic approaches e.g., systems biology profiling technologies   
are needed. 
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1. Introduction  
Polyphenols are a large and heterogeneous group of phytochemicals of plant-based foods, such as 
tea, coffee, wine, cereal grains, vegetables, legumes, fruits and berries. The structural diversity of 
polyphenols extends from simple one-phenol hydroxybenzoic and hydroxycinnamic acids to large 
polymeric macromolecules like proanthocyanidins and ellagitannins. An essential group of phenolic 
compounds are flavonoids encompassing structural classes like flavonols, flavones, flavanols, 
flavanones, anthocyanidins and isoflavones. The estimated intake of dietary polyphenols is 
approximately 1 g/day [1]. Consumption of plant foods is associated with lowered risk of major 
chronic diseases including diabetes, cardiovascular diseases and cancer [2–5]. In vitro and in vivo 
studies on polyphenols show that polyphenols possess anti-inflammatory, antioxidative, 
chemopreventive and neuroprotective activities, suggesting that they could contribute to the health-
protective properties of plant foods. Growing evidence indicates that dietary polyphenols also 
influence glucose and lipid metabolism  
The majority of dietary polyphenols are metabolised by colonic microbiota before absorption, only 
smaller amount being absorbed directly from upper gastrointestinal tract [6]. Gut bacteria modulate 
polyphenols by various mechanisms including hydrolysis, ring-cleavage, reduction, decarboxylation 
and demethylation. The microbial metabolism is a pre-requisite for absorption, and it also modulates 
the biological activity of the compounds. The systemic effects of dietary polyphenols depend largely 
on the synergistic action that polyphenols may exert after entering circulation, and are affected by 
other constituents present in the diet as well as endogenous factors [7,8]. 
Starch and sucrose are the most important dietary carbohydrates. Their digestion, absorption and 
metabolism may be influenced by dietary polyphenols and their metabolites. Most dietary 
carbohydrate is digested in the upper gastrointestinal tract to monosaccharides which are then absorbed 
to the circulation. The elevated glucose concentration in blood promotes secretion of insulin from the 
β-cells of the islets of Langerhans in the pancreas, and insulin mediates the uptake of glucose in 
peripheral tissues including muscle, adipose tissue and kidney, promotes storage of glucose in liver as 
glycogen, and inhibits lipolysis in adipose tissue. Another essential hormone in maintaining the 
glucose homeostasis is glucagon that is secreted from the pancreatic α-cells once the blood glucose 
level begins to fall below normal. Glucagon promotes liver glucose production by inducing 
glycogenolysis and gluconeogenesis to ensure adequate circulating glucose to fuel the body functions.  
Maintenance of glucose homeostasis is of utmost importance to human physiology, being under 
strict hormonal control. Failure of this control can result in the metabolic syndrome, a multi-symptom 
disorder of energy homeostasis encompassing obesity, hyperglycemia, impaired glucose tolerance, 
hypertension and dyslipidemia [9]. The most characteristic abnormality in the metabolic syndrome is 
insulin resistance, which results from interactions between genetic and environmental factors, 
including diet and sedentary lifestyle [10,11]. Metabolic syndrome is the major predisposing factor to Int. J. Mol. Sci. 2010, 11                 
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type 2 diabetes, where defects in both insulin action and insulin secretion are present, but their relative 
contribution varies individually. The disturbance of glucose metabolism is often related to the increase 
of fat mass, especially in the abdominal area and ectopically, to the tissues where fat is not stored in 
normal energy homeostasis [12]. This in turn results in inflammation and exacerbated oxidative stress 
at the whole body level, and malfunction in several organs including pancreas, liver, muscle and 
adipose tissue [13].  
The prevalence of type 2 diabetes is rising exponentially, estimated to reach over 300 million cases 
by year 2030 [14]. Presently, the treatment of metabolic syndrome and prevention of type 2 diabetes 
involves lifestyle modifications like increased physical activity and weight control by reduced caloric 
intake [15,16]. Increasingly, the dietary recommendations for individuals at risk of type 2 diabetes 
emphasise the intake of plant food products, such as whole grains, berries, fruits and vegetables, all 
known to be excellent sources of dietary fibre, but also good sources of variable polyphenolic 
compounds. These compounds may influence glucose metabolism by several mechanisms, such as 
inhibition of carbohydrate digestion and glucose absorption in the intestine, stimulation of insulin 
secretion from the pancreatic cells, modulation of glucose release from liver, activation of insulin 
receptors and glucose uptake in the insulin-sensitive tissues, and modulation of hepatic glucose output 
(Figure 1).  
Figure 1. Potential sites of action of dietary polyphenols on carbohydrate metabolism and 
glucose homeostasis.  
 
 
Dietary polyphenols are found in distinctive combinations of metabolites from different chemical 
classes. The biochemical properties and resulting health-beneficial bioactivities in different plant 
groups or even different species are thus discrete, having different impact on different health 
conditions [3]. In terms of metabolic syndrome and type 2 diabetes, the up-to-date most extensively 
studied plants and metabolites include soy, that is one of the few edible plants having high Int. J. Mol. Sci. 2010, 11                 
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concentrations of isoflavonoids [17]; tea, mainly for condensed tannins, in particular epigallocatecin 
gallate [18]; coffee, for phenolic acid content [19]; grape especially for the presence of resveratrol 
[20]; apple for rich flavonoid content [21] and several herbs often possessing highly distinct 
phytochemical profiles, e.g., high content of terpenoids [22]. Also different berry species like 
cranberry, strawberry and blueberry have been addressed to possess capacity to protect from diabetes, 
and the studies have most often focused on the anthocyanin metabolite class [23]. Similarly, the whole 
grain products are intensively studied not only for the high fibre content but also for the rich phenolic 
compound repertoire that may have beneficial effect on glucose homeostasis [24]. Whilst the results 
from dietary human interventions are still scarce, there is a wealthy of data published with different 
diabetic animal models. The most common ones are rat and mice models with diet-induced diabetes, 
thereby resembling the type 2 diabetes in humans, and the models with destruction of pancreas by 
allozan or streptotozin treatment resulting in insulin deficiency. Various in vitro studies have been 
performed by different cell lines of adipose, hepatic, pancreatic and myotube origin.  
This review will demonstrate the potential of dietary phenolic phytochemicals in maintenance of 
glucose and energy homeostasis and in suppression of metabolic syndrome and type 2 diabetes as 
evidenced by rapidly expanding literature. However, the antioxidant role of these compounds in 
metabolic syndrome, extensively reviewed recently [25,26], is not discussed herein.  
2. Influence of Polyphenols on Carbohydrate Digestion and Glucose Absorption in the Intestine 
Food and beverages high in available carbohydrates such as starch or sucrose induce postprandial 
hyperglycemia, hyperinsulinemia and other hormonal and metabolic disturbances. The rapid 
absorption of glucose challenges the regulatory mechanisms of glucose homeostasis, and habitual 
consumption of high-glycemic diets may therefore increase the risk for obesity, type 2 diabetes and 
cardiovascular disease [27]. Carbohydrate digestion and glucose absorption are obvious targets for 
better glycemia control after high-carbohydrate meals. -Amylase and -glucosidase are the key 
enzymes responsible for digestion of dietary carbohydrates to glucose. The liberated glucose is 
absorbed across the intestinal enterocytes via specific transporters. Inhibition of the digestive enzymes 
or glucose transporters would reduce the rate of glucose release and absorption in the small intestine 
and consequently suppress postprandial hyperglycemia. 
2.1. Carbohydrate Digestion 
Starch is composed of amylose, which is a linear -1,4-linked glucose polymer, and highly 
branched amylopectin consisting of linear -1,4-linked glucose chains with -1,6-linked branch 
chains. Salivary and pancreatic -amylases catalyze the endo-hydrolysis of -1,4-glucosidic linkages 
releasing mainly maltose, maltotriose and related -1,6-oligomers. Further digestion takes place in the 
small intestinal brush border by -glucosidases, which hydrolyze the terminal -1,4-linked glucose 
residues as the final step in the digestion of dietary carbohydrates to release glucose. The   
-glucosidase activities, first described as maltases, are associated with maltase-glucoamylase and 
sucrase-isomaltase [28–30]. In addition to -1,4-glucosidic activity, sucrase-isomaltase displays 
specific activities against the -1,2 linkages of sucrose and -1,6 linkages of isomaltose. Int. J. Mol. Sci. 2010, 11                 
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A variety of polyphenols have been shown to inhibit -amylase and -glucosidase activities in vitro 
(Table 1). The inhibitory polyphenols include flavonoids (anthocyanins, catechins, flavanones, 
flavonols, flavones and isoflavones), phenolic acids and tannins (proanthocyanidins and ellagitannins). 
In addition, in vitro inhibitory activities have been reported for polyphenolic extracts of foods, 
including berries (strawberries, raspberries, blueberries and blackcurrants), vegetables (pumpkin, 
beans, maize and eggplant), colored grains such as black rice, green and black tea, and red wine  
(Table 2). In the studies, maltose, sucrose or p-nitrophenyl--D-glucopyranoside have been used as 
substrate for -glucosidase activity. 
Table 1. Effect of polyphenols on carbohydrate homeostasis measured in vitro. 
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Anthocyanins                                  
Cyanidin 3-galactoside     [191]                            
Cyanidin 3-rutinoside     [192]                            
Cyanidin 3-sambubioside  [183]  [183]                            
Cyanidin 3-glucoside                 [70]                
Acylated anthocyanins     [193,194]                            
Delphinidin 3-glucoside                 [70]                
Catechins                                  
Catechin     [43]  [33,37]                         
Epicatechin              [78]     [78,79]             
Catechin gallate     [43]                            
Epi(gallo)catechin     [33,43,195]  [37]                         
Epi(gallo)catechin gallate 
   [41,184]  [35–
37] 
[65]     [65]     [95]     [135]  [135–137]  [136,138
,151] 
Theaflavin                    [151]   
Theaflavin gallate     [41]                           [151]  
Theaflavin digallate 
                  [151]   
 
Flavonols, flavones, 
flavanones 
   [184]                            
Naringenin        [38]                         
Naringin                [143,144]  [143,144]  
Quercetin  [184,185] [43,184]  [37,39] [73]  [76,77]     [73,76,79]     [101]       
Quercetin 3-glucoside        [34]                         
Quercetin 4’-glucoside        [34]                         
Quercetin 3-rhamnoside      [196]                            
Rutin 
         [65, 
74] 
   [65]  [85]             
Myricetin  [184,185]  [184]  [37]                         
Hesperidin                [143,144]  [144]   
Apigenin        [37]  [73]        [73,85]             
Luteolin  [184–
187] 
[184,186]     [73]        [73]             
Luteolin 7-glucoside  [186]  [186]                            
Puerarin                       [205]          
Kaempferol                           [101]       
Kaempferol 3-
neohesperidoside 
                     [102]          Int. J. Mol. Sci. 2010, 11                 
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Table 1. Cont. 
 
Table 2. Effect of dietary plants or extracts on carbohydrate homeostasis measured in 
vitro. 
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Acerola     [196]  [42]                         
Berries; strawberry, 
raspberry, 
blueberry, 
blackcurrant 
[189]  [189,213]                            
Blueberry        [72]    [72]    [114] [114]      
Black rice     [214]                             
Rice bran                 [150]     
Gingko biloba  [44,207]  [44,207]                            
Red wine  [189]  [215]                            
Tea 
green, black 
[189,208,
209,210] 
[209,215]                    [181]  [218]  [218]   
Vegetables; 
pumpkin, beans, 
maize, eggplant 
[211,212]  [211,212]                            
Soy              [64]     [63,64,216]        [63]  [63]  [140] 
Grape              [80]                   
Grape seed                        [108, 
109] 
[108]   [173]     
Bitter melon                        [110]  [111]       
Canna indica root                        [122]          
Cinnamon                           [217]       
Artemisia 
dracunculus 
              [219]     
 
Isoflavones                                  
Genistein     [184,197]           [69,20
1,202] 
[62,69,202
–204] 
      [139]  [62,139] 
 
 
Daidzein     [184,186]                      [62,139]  [62,139]   
3,5-Diprenylgenistein                       [120]          
6,8-Diprenylgenistein                       [120]          
Alpinumisoflavone                       [120]          
Derrone                       [120]          
Phenolic acids                                  
Caffeic acid  [188] [43,195,198]  [33]                         
Chlorogenic acid  [187,188]  [43,183]  [33,43]              [94]          
p-Coumaric acid     [195]                            
Ferulic acid     [195, 198]  [33]        [67]  [67]  [94]     [150]     
Gallic acid     [195]                            
Tannic acid  [187]  [195,199]  [33]                         
Ellagitannins  [189]                                
Proanthocyanidins  [190]  [190, 200]                            
Other phenolics                                  
Aspalathin                 [71]     [71]          
Penta-galloyl-glucose                          [206]       
Resveratrol                       [96,98]         [154] Int. J. Mol. Sci. 2010, 11                 
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2.2. Glucose Absorption 
Intestinal absorption of glucose is mediated by active transport via the sodium-dependent glucose 
transporter SGLT1 and by facilitated sodium-independent transport via the glucose transporter GLUT2 
[31,32]. On the luminal side of the intestinal brush border membrane, two Na
+ ions bind to SGLT1 and 
produce a conformational change that permits glucose binding, followed by another conformational 
change to allow glucose and Na
+ to enter the enterocyte. Glucose is released from the enterocyte via 
GLUT2, a high capacity facilitative transporter in the basolateral membrane, to enter the circulation. 
The influence of polyphenols on glucose transporters has been studied in vitro by using intestinal 
brush border membrane vesicles or everted sacs and Caco-2 cells. Several flavonoids and phenolic 
acids have been shown to inhibit glucose transport (Table 2). The Na
+-dependent SGLT1-mediated 
glucose transport was inhibited by chlorogenic, ferulic, caffeic and tannic acids [33], quercetin 
monoglucosides [34], tea catechins [35–37] and naringenin [38]. The glucose transport by GLUT2 was 
inhibited by quercetin, myricetin, apigenin and tea catechins [37,39]. 
2.3. Postprandial Glycemia 
Effects of polyphenols, polyphenolic food fractions, and foods and beverages rich in polyphenols 
on postprandial blood glucose responses have been investigated in animal models and in human 
studies. Either glucose, maltose, sucrose, starch or various meals have been used as the carbohydrate 
challenge. 
Animal studies. Diacylated anthocyanin as well as an anthocyanin extract from purple sweet potato 
reduced the blood glucose and insulin responses to maltose administration in rats [40]. The lack of 
effect after sucrose or glucose administration indicates that the anti-hyperglycemic effect was achieved 
by maltase inhibition, and not by inhibition of intestinal sucrase activity or glucose transport. Also a 
tea polyphenol, theaflavin 3-O-gallate, was effective in suppressing the postprandial glucose response 
to maltose [41].  
A crude Acerola polyphenol fraction (containing anthocyanins) significantly reduced the plasma 
glucose level after administration of maltose or glucose in mice, suggesting inhibition of -glucosidase 
and intestinal glucose transport [42]. A leaf extract of Nerium indicum, a plant used as a folk remedy 
for type 2 diabetes in Pakistan, was found to reduce the postprandial rise in blood glucose in maltose- 
or sucrose-loaded rats [43]. A similar response was obtained with chlorogenic acid, which was 
identified as the major -glucosidase inhibitor in the leaf extract.  
Gingko biloba extracts and their flavonoid fraction reduced the elevation of rat plasma glucose level 
after oral administration of starch, maltose, sucrose or glucose [44]. Also in diabetic rats, the flavonoid 
fraction attenuated the glucose response to sucrose and glucose administration. When diabetic rats 
were administered glucose with quercetin, hyperglycemia was significantly decreased compared to 
administration of glucose alone [39]. 
Human studies. Apple juice contains polyphenols such as chlorogenic acid and phloridzin, with 
higher levels in cloudy juice compared to clear juice. When nine healthy subjects consumed a 25 g 
glucose load in 400 mL of commercial apple juices, the mean plasma glucose concentrations were 
significantly lower at 15 and 30 min after ingestion of clear apple juice, and significantly lower at  
15 min but significantly higher at 45 and 60 min after ingestion of cloudy apple juice compared to Int. J. Mol. Sci. 2010, 11                 
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control drink [45]. The effects of apple juices on plasma glucose, insulin, GIP and GLP-1 
concentrations were consistent with delayed absorption of glucose. 
Berries are rich sources of polyphenols, especially anthocyanins, flavonols, proanthocyanidins and 
phenolic acids. In twelve healthy subjects, ingestion of sucrose (35 g) with berries (150 g of purée 
made of bilberries, blackcurrants, cranberries and strawberries providing nearly 800 mg polyphenols) 
produced a different postprandial glycemic response compared to the control without berries but with 
comparable profile of available carbohydrates [46]. The shape of the plasma glucose curve with 
reduced concentrations in the early phase and a slightly elevated concentration in the later phase 
indicates delayed response due to berry consumption. Berries also significantly decreased the peak 
glucose increment. Reduced rates of sucrose digestion and/or absorption from the gastrointestinal tract 
are the most probable mechanisms underlying the delayed and attenuated glycemic response. In 
another study, consumption of cranberry juice sweetened with high-fructose corn syrup resulted in 
different (but not statistically significant) pattern of postprandial glycemia compared to the similar 
amount of the sweetener in water [47]. 
In ten type 2 diabetic patients, red wine (200 mL) taken during a midday meal induced a smaller 
increase in blood glucose versus the same meal accompanied by an equivalent amount of water, with 
no effect of plasma insulin levels [48]. Comparable results were obtained with tannic acid, a 
polyphenolic component of red wine. Ethanol had no effect. In ten healthy young adults, sugar cane 
bioflavonoid extract reduced the postprandial glycemic response to a high-glycemic starchy meal 
composed of wheat biscuits and milk [49]. Ingestion of cinnamon (6 g) with rice pudding significantly 
lowered blood glucose response in the postprandial phase (15, 30 and 45 min) in 14 healthy subjects 
[50,51]. However, in another study of the same group [51], cinnamon (3 g) reduced postprandial serum 
insulin and increased GLP-1 concentrations without significantly affecting blood glucose response. 
Cinnamon has high content of proanthocyanidins. 
Gastrointestinal hormone (GIP and GLP-1) profiles after consumption of 25 g glucose with coffee 
(400 mL containing 350 mg chlorogenic acid) indicated delayed intestinal absorption of glucose in 
nine healthy subjects [52]. The authors concluded that chlorogenic acid, the major polyphenol of 
coffee, might attenuate the intestinal glucose absorption rates and shift the site of glucose absorption to 
more distal parts of the intestine. In overweight men, chlorogenic acid (1 g) reduced early glucose and 
insulin responses during an oral glucose tolerance test [53]. Attenuated glycemic response has also 
been observed when sucrose (25 g) was consumed in chlorogenic acid enriched instant coffee [54]. 
When either 250 mL of coffee or tea was consumed with test meals, they increased the overall mean 
peak blood glucose concentration, but did not significantly affect the incremental area under the 
glucose response curve of the meals [55]. Coffee and tea contain caffeine, which increases 
postprandial glycemia and impairs glucose tolerance [52,56,57]. Caffeinated coffee ingested with 
either a high or low glycemic meal significantly impaired acute blood glucose management and insulin 
sensitivity compared with ingestion of decaffeinated coffee [57]. Instant black tea consumed with 
glucose reduced the late phase plasma glucose response with a corresponding increase in insulin [58]. 
The attenuation of late postprandial glycemia may be explained by an elevated insulin response 
following stimulation of pancreatic -cells rather than by retarded absorption of glucose. 
In conclusion, the scientific evidence on the potential of polyphenolic compounds to retard 
carbohydrate digestion and absorption and to suppress hyperglycemia in the postprandial state is Int. J. Mol. Sci. 2010, 11                 
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promising. However, it is mostly based on simple in vitro and animal studies. Current evidence from 
human studies suggests that beverages such as apple juice, red wine and decaffeinated coffee as well 
as berries and cinnamon may improve short-term glycemic control. For substantiation of the benefits 
of polyphenols in the control of postprandial glucose homeostasis, more clinical studies involving 
subjects with normal and impaired glucose metabolism are needed. These studies should be focused on 
the effects of dietary polyphenols on glycemic responses induced by starch and sucrose, the main high-
glycemic carbohydrates in our diet.  
3. Influence of Polyphenols on Pancreatic β-cell Function 
Insulin secretion by the pancreas involves numerous reactions which are potential targets for the 
action of polyphenols. Upon high blood glucose concentrations pancreatic β-cells respond to the 
increased demand of insulin by various mechanisms including increased insulin secretion, 
hypertrophy, proliferation of existing β-cells and formation of new ones from progenitor cells. The 
insulin release from β-cells is a cascade starting from the uptake of glucose by the GLUT2 
transporters. Glucose enters a cycle of enzymatic reactions involving phosphorylation, leading to 
increased ATP content in the cells, and causing inactivation of ATP-sensitive potassium channels on 
the cell membrane. The membrane depolarizes and leads to calcium channel opening and subsequent 
flow of Ca
2+ into cell. The rise in Ca
2+ concentration promotes release of insulin by exocytosis from 
existing storage granules [59,60].  
Prolonged hyperglycemia and hyperlipidemia, typically within development of metabolic 
syndrome, leads to the dysfunction of the pancreatic β-cells, reflected in autocrine insulin resistance, 
impaired insulin secretion, decreased expression of genes involved in insulin production and finally 
decrease in β-cell mass caused by apoptosis. Therefore the insulin deficiency related to metabolic 
syndrome in pancreas is due to both the cellular damage and the impaired efficiency in the synthesis of 
insulin [61]. 
The most extensively studied sources of dietary polyphenols in terms of pancreatic function and 
insulin secretion is soy, and especially its isoflavonoids, genistein and daidzein. The most commonly 
applied approaches in determining the effect of polyphenols on pancreatic insulin metabolism are 
measurement of insulin secretion or/and content in cultured pancreatic cell lines, either with or without 
glucose stimulation, and examination of perfused pancreas either after feeding trial/intraperitoneal 
injection or by directly applying the compound of interest on the isolated islets. Many of these studies, 
reviewed below and summarized in Tables 1 and 2, examine also the molecular mechanisms behind 
the observed effects of polyphenols. 
3.1. In Vivo Studies with Animal Models 
There are few recent studies where soy isoflavonoids at physically achievable concentrations have 
shown positive impact on β-cell function. Choi et al. [62] used genistein and daidzedin in order to 
study factors related to glucose and insulin metabolism using a non-obese diabetic mouse model which 
spontaneously develops autoimmune insulin dependent diabetes mellitus. Both isoflavonoids (0.2 g/kg 
genistein or daidzein for nine weeks) preserved the insulin production by the β-cells, whereas mice fed 
the control diet had no insulin production [62]. Another in vivo study performed in non-obese mice Int. J. Mol. Sci. 2010, 11                 
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(streptozotocin (STZ) induced diabetic model) fed with fermented soybean, a Korean food 
‘chungkukjang’ (5 g/100 g of diet for 6 weeks), similarly showed that the insulin concentration in 
pancreas was higher in the soybean- fed mice than in the non-treated control mice. In addition to 
enhancing the insulin production in pancreas the treatment also seemed to contribute to improved 
insulin sensitivity in peripheral tissues, thus necessitating smaller amounts of insulin and preventing 
pancreatic exhaustion [63]. The same line in results was obtained also by Lu et al on high-isoflavone 
soy protein fed STZ-diabetic rats [64]. 
3.2. Effects Observed in Cell Culture Analyses 
Epigallocatechin gallate (EGCG) and rutin were examined for their ability to attenuate the 
glucotoxicity in rat insulinoma pancreatic β-cells (RIN m5F) [65]. The treatment increased glucose 
dependent insulin secretion, and was able to promote effective secretion of insulin also under chronic 
high glucose incubation when insulin secretion is suppressed by glucotoxicity (33 mM, 48 h), 
suggesting that both EGCG and rutin might preserve the glucose- sensing ability during 
hyperglycemia. EGCG and rutin elevated the intracellular ATP, suggesting that the increase in insulin 
secretion is mediated by enhancing the normal, glucose induced insulin secretion that is dependent on 
ATP concentrations. Interestingly, epicatechin, the precursor of EGCG, was found to inhibit insulin 
secretion when tested on INS-1 cells [66].  
A very detailed study on the effects of dietary phenolic acids on pancreas function was carried out 
with cinnamic acid derivatives in INS-1 cell culture and perfused rat pancreas [67]. Among the 
differentially substituted cinnamic acid derivatives, the most prominent insulin releasing agents were 
the ones containing m-hydroxy and p-methoxy residues on the phenol ring structure, whereas cinnamic 
acid (no substituents in the phenol ring) was inactive. The structure promoting insulin secretion most 
effectively was the one of ferulic acid, containing p-hydroxy and m-methoxy structure, as it enhanced 
insulin secretion in a dose-dependent manner (1–100 µM), being significant already at 1 µM 
concentrations. Notably, the assays were performed in absence of glucose, whereas the majority of 
other reports have focused on glucose dependent insulin release. The results were verified also with 
treatment of perfused rat pancreas and intravenous administration in normal rats, where the increase in 
plasma insulin was detected in fasting state. Interestingly, isoferulic acid, the stereoisomer of ferulic 
acid did not have any effect on insulin releasing properties. This finding corroborated earlier results 
showing that plasma glucose lowering properties of isoferulic acid are due to increase in glucose 
uptake and retarding of hepatic gluconeogenesis, without any effect on pancreatic insulin output [68] 
In one of the most recent studies isoflavonoids were shown to improve glucose stimulated insulin 
secretion in INS-1E pancreatic cell line but this effect was not due to modulation of insulin synthesis, 
since there was no difference on the insulin concentration in the genistein treated and non-treated cells. 
However, the insulin secretion upon glucose stimulation was significantly increased after 48h pre-
treatment with genistein (1–5 µM). It was suggested that the effect of genistein on promoting glucose 
dependent insulin secretion was not mediated by the same mechanism as glucose stimulation alone, 
since several cellular factors related to glucose-induced insulin secretion, e.g., cellular ATP 
concentration, were not changed. The finding that cellular Ca
2+ levels were elevated by the genistein 
treatment suggests that the improvement in insulin secretory function may be attributable to Int. J. Mol. Sci. 2010, 11                 
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modulation of Ca
2+ signaling and cAMP/protein kinase A (AMPK) function, but the mechanism is not 
yet clear [69]. The effect of genistein on insulin secretion was observable also in mouse and human 
pancreatic islets showing non-species-specific and biologically relevant effect.  
Also numerous other publications report on the insulin secretagogic activities of dietary phenolics 
e.g., anthocyanidin and anthocyanin compounds in INS-1 cell line [70], aspalathin, component from 
rooibos tea Aspalathus linearis, in RIN-5F cells [71], and compounds isolated from Eriobotrya 
japonica in INS-1 Cells [66]. 
There are also indications for the function of polyphenols on β-cells by other mechanisms besides 
affecting insulin secretion. Ethanol extracts from the root, stem, leaf and fruit of the Canadian lowbush 
blueberry  Vaccinium angustifolium, a very rich source of flavonoids, were analyzed for insulin 
secretagogue and proliferative effects [72]. The insulin secretion was measured from growth arrested 
(tetracycline-treated) β-cells in order to distinguish the insulinotropic effect from the cell proliferative 
effect. Only slight enhancement was observed in the glucose stimulated insulin secretion with the 
treatment by leaf and stem extracts, but the effect on the cell proliferation rate was found to be 
significantly increased by the treatment with the fruit extract when compared to vehicle-only control, 
suggesting a potential capability to restrain β-cell damage in metabolic syndrome. 
Another study showing β-cell protective effect of flavonoids was performed by mixtures of 
flavonoids quercetin, luteolin and apigenin in RINmF5 cells [73]. Flavonoids showed anti-
inflammatory action in a treatment with interleukin 1β (IL-1β) and interferon γ (IFN- γ), and the effect 
was verified at transcriptional analysis of inflammation-related genes, suggesting a role for flavonoids 
in the restoration of insulin secretion capacity by preventing the cytokine-induced β-cell damage. 
3.3. Effects Observed in Isolated/Perfused Pancreas 
Oral administration of rutin (100 mg/kg, 45 days) was shown to promote β-cell viability in STZ 
induced diabetic rats [74]. It was suggested that the β-cell restoring effect of rutin was due to enhanced 
ability to scavenge free radicals and mediate antioxidant enzyme activity in the pancreas. Similarily, 
quercetin, the aglycon molecule of rutin, showed β-cell restoration when used as dietary supplement 
(0.5% of diet for 14 days) in STZ induced diabetic mice [75]. Gene expression analysis showed that 
quercetin restored the cell proliferation capacity inhibited by STZ treatment, and resulted in higher 
plasma insulin levels. In addition oxidative stress markers were reduced in pancreas, further 
ameliorating the oxidative damage associated with diabetes. Quercetin has been studied also in   
STZ-diabetic rats by intraperitoneal injection, and the preservation of islet cells and restoration of 
insulin production has been observed in two studies [76,77]. 
Intraperitoneal injection of (−)epicatechin in alloxan treated mice demonstrated β-cell- regenerative 
capacity [78]. Similarily, (−)epicatechin or quercetin promoted increased release of insulin when 
isolated rat islets were exposed to them, whereas naringenin and chrysin inhibited it [79]. Additional 
observations with dietary sources of polyphenols include the protection of non-obese diabetic mice 
pancreatic islets from infiltration of immune cells and induction of insulitis by feeding grape powder 
and high vitamin A supplement [80]. An interesting approach was taken to study olive mill waste 
which is a rich source of phenolic compounds, especially phenylethanol compound hydroxytyrosol. 
Fractions of olive mill waste were studied for a range of hypoglycemic and antioxidative effects, Int. J. Mol. Sci. 2010, 11                 
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including the effect in insulin secretion in alloxan- induced diabetic rats administered by 
intraperitonial injection. Mainly the purified hydroxytyrosol fraction showed protective action on 
alloxan-damaged β-cells [81].  
Phytochemical- rich extracts from other than dietary plants have also been studied for their impact 
on pancreatic insulin production and release. Studies have focused especially on medicinal plants 
known for their anti-diabetic effects. Seed extracts of Eugenia jambolana enhanced insulin secretion 
from isolated islets of STZ-induced diabetic rats in the presence of 10 mM glucose [82]; eupatilin, a 
flavone from Artemisia princes, elevated pancreatic insulin concentration in type 2 diabetic mouse 
model (db/db) [83]; and aqueous extract from Abutilon indicum, a plant used as traditional medicine in 
Thailand, stimulated insulin secretion from isolated rat islets and INS-1E cells [84]. A fraction 
containing apigenin and rutin from Teucrium polium, a medicinal plant from Iran, mediated insulin 
secretion increase in the presence of STZ on isolated rat pancreatic islets [85].  
In conclusion, it is obvious that the pancreas is one of the targets of dietary polyphenol bioactivity, 
as several of the studied plant extracts and purified compounds exhibit beneficial effects on β-cell 
function and insulin release in different diabetic models. However, no single mechanism has been 
identified to be responsible for the response. For instance, in INS-1E cells genistein did not increase 
the level of intracellular ATP upon the glucose stimulation, whereas treatment of the RIN-m5F cells 
with EGCG and rutin elevated the ATP level [65]. This suggests that the latter treatment enhanced the 
signaling route mediated normally by glucose, whereas the genistein treatment had effect on 
alternative mechanism of insulin secretion. A range of different compounds and plant food extracts 
studied show various activities relevant for insulin secretion, and the activities are different on 
normoglycaemic controls and the subjects with symptoms of metabolic syndrome. The different effects 
of various molecules were highlighted in a study showing that even small changes (e.g., 
hydroxylation) on the molecular backbone result in different insulin- releasing capacity [67]. The 
studies have been made mainly using cell cultures and animal models, and motivate to proceed to 
human controlled trials.  
4. Influence of Polyphenols on Tissue Uptake of Glucose 
Dietary polyphenols may also influence glucose metabolism by stimulating peripheral glucose 
uptake in insulin-sensitive and non-insulin sensitive tissues. Glucose transport pathways can be 
classified either as insulin or non-insulin mediated pathways. Non-insulin mediated glucose uptake 
takes place in all tissues and is responsible for the basic glucose transport into the cells in post-
absorptive state. In contrast the insulin mediated glucose uptake takes place only in insulin sensitive 
tissues. Insulin stimulates the glucose uptake in skeletal muscle, which is the largest site for disposal of 
dietary glucose, and in adipose tissue, whereas in the liver it decreases the hepatic glucose output rate 
by increasing the storage of glucose as glycogen.  
Glucose uptake is mediated by the action of glucose transporters (GLUTs) on the cell surface [86]. 
It is important to point out that among the 13 GLUTs identified so far [87], only GLUT4 is an insulin 
sensitive glucose transporter. Based on sequence comparison, the GLUT isoforms can be grouped into 
three classes. Class I comprises GLUT1–4; class II, GLUT6, 8, 10, and 12 and class III, GLUT5, 7, 9, 
11 and H
+-myo-inositol cotransporter (HMIT) [88]. Tissue- and cell-specific expression of the well-Int. J. Mol. Sci. 2010, 11                 
 
 
1377
characterized GLUT isoforms underlies their specific role in the control of whole-body glucose 
homeostasis. Numerous studies with transgenic or knockout mice support an important role for these 
transporters in the control of glucose utilization, glucose storage and glucose sensing, but more studies 
are needed to elucidate the mechanisms behind.  
Glucose transporters from class I are actively involved in glucose mobilization and uptake. GLUT1 
and GLUT3 are responsible for maintaining the basal glucose uptake, and contrary to GLUT4 are 
abundant in several tissues [89]. GLUT1 is widely distributed in fetal tissues and it is expressed at high 
levels in erythrocytes and endothelial cells of barrier tissues in adults, while GLUT 3 is mostly 
expressed in neurons and placenta. Glucose is transported into and out of liver cells by the 
concentration-driven GLUT2 [90], which is also expressed by renal tubular cells, small intestinal 
epithelial cells that transport glucose and pancreatic beta cells. GLUT4 is expressed by muscle, 
adipose and kidney cells and remains stored in insulin-responsive compartments within the cells until 
insulin mediates its localization on the cell surface. 
The most studied insulin signalling pathway leading to increased muscle glucose uptake involves 
binding of insulin to GLUT4, phosphorylation of downstream insulin receptor substrates (IRS) and 
activation of several signalling enzymes such as phosphatidylinositol-3 kinase (PI3K) and Akt-
serine/threonine kinase. The cascade promotes GLUT4 glucose transporter translocation from an 
intracellular pool to the plasma membrane [91,92]. In addition to PI3K activity, there are also other 
signalling routes involved in the cellular response to insulin stimulation and a detailed overview of the 
basic insulin signalling and regulation of glucose metabolism was reviewed some years ago by Saltiel 
and Kahn [93]. In this sense, a molecular mathematical model of glucose mobilization and glucose 
uptake has been recently developed considering the kinetics of GLUT2, GLUT3 and GLUT4, the 
process of glucose mobilization by glycogen phosphorylase and glycogen synthase in liver, as well as 
the dynamics of the insulin signalling pathway [90]. 
Among the potential compounds stimulating glucose uptake, several foods and plant extracts rich in 
polyphenols have been the object of extensive research during the last years (Tables 1 and 2).The 
methods most commonly used to study the effects of phenolic compounds on peripheral glucose 
uptake are cell culture assays in rat skeletal muscle (rat L6 myotubes) and adipose (3T3-L1) cell lines. 
Most studies reported in the literature so far base their glucose uptake mechanisms in insulin mediated 
pathways, mainly cAMP/protein kinase A (AMPK) and PI3K activation. The insulin-stimulated 
glucose uptake shows to be dose-dependent in most cases.  
4.1. Effects of Pure Compounds on Glucose Uptake 
Chlorogenic acid and ferulic acid caused a modest, but significant increase in 2-deoxy-D-glucose 
transport into L6 myotubes, showing comparable performance to metformin and   
2,4-thiazolodinedione, two common commercial oral hypoglycemic drugs [94]. Purified aspalathin 
from green roiboos extract increased dose-dependently and significantly glucose uptake by L6 
myotubes at concentrations 1–100 μM, irrespective of insulin absence [71]. As aspalathin is capable of 
scavenging intracellular reactive oxygen species (ROS), its antioxidative function may be involved in 
the stimulation of glucose uptake and insulin secretion, and hence glucose homeostasis. An inhibitory 
effect of EGCG was observed in L6 skeletal muscle cells on insulin resistance induced by Int. J. Mol. Sci. 2010, 11                 
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dexamethasone, a glucocorticoid [95]. A 24 h- treatment with EGCG attenuated the effect of 
dexamethasone on glucose uptake and improved insulin-stimulated glucose uptake in a dose-
dependent manner by increasing GLUT4 translocation to plasma membrane [95]. EGCG was able to 
increase the phosphorylation of AMPK, suggesting that the AMPK signalling pathway is likely 
responsible for the EGCG-stimulated GLUT4 translocation. 
Resveratrol increased glucose uptake in C2C12 skeletal muscle cells by activating AMPK [96]. In 
the absence of insulin, the effect of resveratrol on glucose uptake was primarily dependent on AMPK 
activation, without involving PI3K. In the presence of insulin, resveratrol also potentiated the effect of 
insulin on glucose uptake via AMPK activation, but leading to activation of the PI3K-Akt signal 
pathway [96]. Resveratrol treatment during 15 weeks increased both insulin-stimulated whole-body 
and steady-state glucose uptake of both soleus muscle and liver in high cholesterol-fructose-fed rats 
[97]. It enhanced membrane trafficking activity of GLUT4 and increased phosphorylation of IR in 
insulin-resistant soleus muscles. Interestingly the activation of estrogen receptor seems to be crucial 
for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and –independent 
pathways [97]. Additional putative function for resveratrol was found in a study reporting that Akt/ 
protein kinases B (PKB) and GLUT4 or GLUT1 translocation is not involved in resveratrol activation. 
The mechanism seems to involve sirtuin-dependent AMPK activation that may lead to stimulation of 
the intrinsic activity of GLUT4 [98]. Sirtuins are a family of histone/protein deacetylases, among 
which, SIRT1 has been suggested to play a role in regulating glucose homeostasis and may be 
involved in the insulin signalling cascade [99,100].  
Kaempferol and quercetin isolated from the traditional Chinese medicine Euonymus alatus 
improved glucose uptake of insulin stimulated 3T3-L1 mature adipocytes and had no effects on GU 
without insulin [101]. The results indicated that both flavonoids could ameliorate insulin resistance 
peripherally, similar to a PPARγ agonist such as rosiglitazone. Kaempferol 3-neohesperidoside, a 
flavonoid glycoside isolated from Cyathea phalerata, stimulated glucose uptake in rat soleus muscle 
mainly via the PI3K pathway [102]. Another kaempferol derivative, kaempferitrin (3,7-dirhamnoside), 
has recently been shown to inhibit GLUT4 mediated glucose uptake in differentiated 3T3-L1 cells by 
interfering with insulin signaling pathway and also by directly interacting with membrane GLUT4 
[103]. Contradictory, at the same time other authors have found opposite results for kaempferitrin 
treatment of the same cell line, demonstrating increase in the glucose uptake [104]. The latter results 
agreed with the glucose uptake stimulation by kaempferitrin found in rat soleus muscle [105]. This 
suggests that the effect of kaempferitrin on insulin mediated glucose uptake might be a cell type 
specific function. Inhibitory effect on glucose uptake has been observed in adypocyte cells also by the 
isoflavone genistein with concentrations 20–50 µM [106]. 
4.2. Effects of Polyphenol Containing Foods and Plant Extracts on Glucose Uptake 
Several plant based foods and extracts have been reported to enhance glucose uptake in vitro. A 
green tea polyphenolic extract was reported to regulate the expression of genes involved in glucose 
uptake and insulin signalling pathways in the muscle tissue from rats with metabolic syndrome 
induced by a high fructose diet [107]. The tea extract significantly increased the mRNA levels of 
GLUT4 in the muscle. A procyanidin extract from grape seed has been reported as an insulinomimetic Int. J. Mol. Sci. 2010, 11                 
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agent since it stimulates glucose uptake in 3T3-L1 adipocytes and L6E9 muscle cells via PI3K –
pathway [108]. A more detailed study with same approach showed recently that the grape seed extract 
interacts with the insulin receptor inducing its phosphorylation and consequently leading to increased 
glucose uptake via pathway requiring Akt. However, the treatment leads to differential 
phosphorylation of the insulin signalling pathway proteins than insulin does [109].  
Fruit juice extract of Momordica charantia (bitter melon) was shown to stimulate glucose and 
amino acid uptakes into L6 muscle cells in a similar manner to insulin [110]. Pharmacological 
concentrations had inhibitory effects, while physiological concentrations had insulin-like stimulating 
effects, a finding that points out the importance of the concentration of the bioactive compounds in 
stimulating glucose uptake into muscle cells. Water-soluble components in bitter melon also enhanced 
the glucose uptake at sub-optimal concentrations of insulin in 3T3-L1 adipocytes, which was 
accompanied by an increase in adiponectin secretion [111]. Charantin, steroid, glycosides, flavonoids 
and their derivatives may in part be responsible for the observed up-regulatory activities of glucose 
uptake and mRNA expression of GLUT4, PI3K and PPARγ in bitter melon extracts but more research 
is needed to confirm this statement [112]. Another study on the effect of fruit juices on the glucose 
uptake was performed with blueberry juice. The biotransformation of the juice with a novel strain of 
bacteria isolated from the blueberry flora (Serratia vaccinii) increased its phenolic content and 
antioxidant activity [113] and modified its biological activity [72]. The juice extract increased AMPK 
phosphorylation and glucose uptake in both muscle cells and adipocytes, but it also inhibited 
adipogenesis [114]. 
Common spices, such as cinnamon, cloves, turmeric and bay leaves also show insulin-like activity 
in vitro [115]. For instance, cinnamon polyphenols with doubly linked procyanidin type-A polymers 
appear to be unique for their insulin- like activity [115]. A water-soluble cinnamon extract showed to 
increase the activity of autophosphorylation of the IR and decrease the activity of tyrosine phosphatase 
in vitro [116]. The mechanism of cinnamon’s insulin-like activity may be in part due to increases in 
the amounts of IRβ and GLUT4 [117]. In vivo insulin-regulated glucose utilization was also enhanced 
by cinnamon extracts by increasing glucose uptake in rats with insulin resistance induced by a high-
fructose diet [118,119].  
Several plant extracts from plants used in traditional medicine have been as well reported to 
promote insulinotropic / insulinomimetic activities. Four isoflavonoids (genistein-derivatives), recently 
identified from a branch extract fraction of the Vietnamese traditional herb Tetracera scandens, 
exhibited significant glucose uptake activity both in basal and insulin-stimulated skeletal muscle cells 
in a dose-dependent manner. AMPK activation and GLUT4 and GLUT1 expressions appear to be 
involved in the glucose uptake stimulation mechanism [120]. A recent review has also reported that 
penta-galloyl-glucose (PGG), a polyphenolic compound highly enriched in a number of medicinal 
herbals, exhibits multiple biological activities relevant in diabetes prevention [95]. Both β-PGG and its 
anomer α-PGG have showed insulin-mimicking activity in the absence of insulin, and α-PGG was 
more potent than β-PGG [121]. α-PGG itself stimulated glucose uptake in 3T3-L1 adipocytes. 
However, α-PGG weakened the activity of insulin if treated together. α-PGG induced phosphorylation 
of the IR, PI3K and Akt, and stimulated membrane translocation of GLUT4. Plant root extracts can 
also exert glucose uptake enhancement properties. For example, the aqueous extract of Canna indica 
root (Cannaceae), rich in flavonoid compounds, caused a dose- and time- dependent induction of Int. J. Mol. Sci. 2010, 11                 
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glucose uptake activity in L8 muscle cells [122]. The authors suggested that GLUT1 protein synthesis 
and the activation of PI3K are critical for the increase in glucose transporter activity at the plasma 
membrane. 
In conclusion, insulin stimulates glucose uptake in skeletal muscle and adipose tissue primarily by 
eliciting the translocation of GLUT4 from an intracellular pool to the plasma membrane [123]. Current 
data suggest that polyphenols mainly affect glucose transport and insulin-receptor function, both of 
which play essential roles in diseases related to carbohydrate metabolism [124]. To date glucose 
uptake data from polyphenols mainly derives from animal cell culture studies. The most likely 
mechanism implies the PI3K activity signaling route. Recent studies use amounts of phenolic 
compounds closer to physiological range. However, doses of relevance to human health are still 
unknown, and deserve further research. 
5. Influence of Polyphenols on Liver Function to Maintain Glucose Homeostasis 
Liver plays a major role in the regulation of blood glucose levels in tight cooperation with 
peripheral tissues. As estimated, liver is responsible of taking up one third of the postprandial glucose 
[125], and stores effectively glucose as glycogen via glycogenesis. In fasted state, liver is the main 
regulator of maintaining stable blood glucose levels and produces glucose by two different routes 
either by breaking down glycogen (glycogenolysis) or by synthesising glucose from other metabolites 
such as pyruvate, lactate, glycerol and amino acids (gluconeogenesis). The key enzymes responsible 
for the regulation of glycogenesis are glucokinase (GK) and glycogen synthase (GS). Pyruvate 
carboxylase, phosphoenolpyruvate carboxykinase (PEPCK), fructose-1,6-bisphosphatase, and glucose-
6-phosphatase are the major enzymes responsible of the regulation of gluconeogenesis [126].  
Several factors influence hepatic glucose homeostatic control. At hormonal level insulin and 
glucagon directly regulate hepatic glucose metabolism. For instance, in fed state insulin suppresses 
liver glucose production and output via insulin receptor pathway [127]. Furthermore, the central 
nervous system mediates part of the effects of insulin and of other signals such as long chain fatty 
acids (LCFAs) to exert higher control on hepatic glucose metabolism [128,129]. In type 2 diabetes and 
insulin resistant state the control of hepatic glucose metabolism and hepatic glucose output are 
disturbed, and the inability of the liver to respond to insulin results in severe defects in the regulation 
of glucose homeostasis such as increased hepatic glucose output and hyperglycemia. Non-alcoholic 
hepatic steatosis, the accumulation of triglycerides in the liver that might lead to fibrosis, is clearly 
associated with hepatic insulin resistance. However, it is not clear whether insulin resistance causes the 
excessive accumulation of triglycerides (TG) in liver, or whether the increase in TG itself plays a 
causal role in the development of hepatic or systemic insulin resistance [130]. In mice, a high-fat diet 
has been shown to first deteriorate hepatic insulin sensitivity in association with hepatic accumulation 
of short to medium chain fatty acylcarnitines, prior to affecting peripheral insulin sensitivity [131]. 
Several studies indicate improved liver glucose and lipid metabolism in normal, obese and diabetic 
mouse or rat models after treatment with different polyphenol-rich diets. The following section 
discusses the potential mechanisms of effects of polyphenols on glucose metabolism in liver. Int. J. Mol. Sci. 2010, 11                 
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5.1. Effects of Green Tea and Epigallocatechin Gallate (EGCG)  
Tea catechins and their effects on liver glucose metabolism have been effectively studied in animal 
and cell culture models. Green tea extracts and green tea catechins such as epigallocatechin alone have 
been shown to decrease blood glucose levels and concomitantly also liver triglyceride contents. In 
streptozotocin-induced diabetic rats oral administration of EGCG (25 mg/kg b.w./day) for eight weeks 
significantly alleviated the increase in serum glucose levels and serum TG levels [132]. However, the 
study did not include any tissue specific analyses. Supplementation of the diet with 0.5% and 1.0% 
green tea for six weeks reduced liver TG concentrations 27–30% in fructose-fed ovariextomized rats 
as compared to fructose and starch fed control diets [133]. Several other studies have also shown 
reduced blood glucose levels and liver TG contents after feeding with green tea or EGCG. For 
instance, supplementation of high-fat diet (60% energy as fat) fed mice with dietary EGCG (3.2 g/kg 
diet) for 16 weeks resulted in decreased blood glucose levels and decreased liver TG contents [134]. 
The potential mechanisms explaining how liver could contribute to the reduced blood glucose levels 
in green tea and EGCG treated animal models have been studied as well. Wolfram et al. [135] assessed 
glucose and insulin tolerance in db/db mice and investigated the effect of 5–7 weeks EGCG 
supplementation on gene expression in liver tissue using real-time quantitative PCR (RT-PCR). EGCG 
supplementation (2.5–10.0 g/kg) resulted in decreased blood glucose levels in a dose dependent 
manner as tested by OGTT. In the fed state plasma glucose, free fatty acid and TG levels were lower 
and insulin levels higher in EGCG-treated db/db mice than in control mice. EGCG treatment increased 
the expression of liver glucokinase (glycogenic enzyme), carnitine palmitoyl transferase-1β and 
decreased the expression of gluconeogenetic enzymes phosphoenolpyruvate carboxykinase (PEPCK). 
The authors suggested that the potential mechanisms to explain the T2DM amelioration by the dietary 
supplementation of EGCG could be the reduced endogenous liver glucose production and increase in 
glucose-induced insulin secretion [135]. Furthermore, DNA microarray analysis of H4IIE rat 
hepatoma cells exposed to EGCG (50µM), showed that genes involved in the synthesis of fatty acids, 
triacylglycerol, and cholesterol were strongly downregulated, also genes involved in gluconeogenesis 
were downregulated whereas genes involved in glycogenesis were upregulated. 
These findings are in line with cell culture studies that have shown reduced hepatic gluconeogenesis 
and glucose output after exposure to EGCG or green tea extract [136,137]. For instance, Collins et al. 
[136,137] studied the role of EGCG in hepatic gluconeogenesis using isolated hepatocytes exposed to 
physiologically relevant concentrations of EGCG (≤1 µM). EGCG decreased glucose production by 
inhibiting expression of the gluconeogenetic enzymes (PEPCK and glucose-6-phosphatase) in a 
similar manner to insulin. However, EGCG was not found to activate the insulin signalling pathway. 
Further tests showed that EGCG activated AMPK, which was shown to be necessary for the observed 
inhibition of gluconeogenetic enzyme expression. AMPK activation was mediated by the calmodulin-
dependent protein kinase kinase CaMKK [136]. Furthermore, ROS production induced by EGCG was 
shown to be required for the activation of AMPK and inhibition of gluconeogenesis. The study by 
Collins et al. showed that EGCG exerts toxic effects on primary hepatocytes already at concentration 
of 10 µM. Other studies have found EGCG to have similar effects on hepatic glucose metabolism, 
though with concentrations exceeding 10 µM [137,138]. Int. J. Mol. Sci. 2010, 11                 
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5.2. Effect of Soy Isoflavones, Genistein and Daidzein 
Similarly to green tea also soy and soy isoflavones genistein and daidzein supplementation   
(0.2 g/kg) have been found to decrease blood glucose levels and to reduce liver TG concentrations in 
db/db mice model [139] and in non-obese diabetic mice [62]. Both studies found reduced glucose-6-
phosphatase and PEPCK liver activities and increased glucokinase activities suggesting that genistein 
and daidzein suppresses liver glucose output. Cederroth et al. [140] studied the mechanisms behind the 
effects of soy supplementation rich in equol, daidzein and genistein, in normal CD-1 mice. 
Phytoestrogen- rich supplementation (198 ppm daidzein and 286 ppm genistein equivalents in the high 
phytoestrogen diet) from conception to adulthood was found to activate AMPK in liver but also in 
white adipose tissue and muscle. The authors hypothesised that high-phytoestrogen-fed mice would 
have altered mitochondrial metabolism and found that the expression of peroxisome proliferator-
activated receptor α (PPARα) and its coactivator peroxisome proliferator-activated receptor γ 
coactivator (PGC-1α) were upregulated in liver, white adipose tissue and muscle suggesting improved 
fatty acid β-oxidation [140]. Potentially, in normal (non-obese) mice activation of PPARα could lead 
to change from glucose utilization to fatty acid oxidation to produce fuels, instead of creating new TGs 
[141]. Increased fatty acid β-oxidation might protect against non-alcoholic hepatic steatosis and 
therefore could also improve insulin sensitivity and glucose metabolism in liver. Furthermore, 
decrease in hepatic TG pools has been shown to correlate with improved insulin sensitivity [130]. 
However, the role of TGs in the development of insulin resistance is not yet clear. Chungkukjang (a 
fermented soybean food) supplementation also resulted in significantly higher hepatic GK activity and 
decreased activity of gluconeogenic enzymes G6Pase and PEPCK in db/db mice when compared to 
control group [142]. However, also insulin secretion was improved after Chungkukjang 
supplementation. 
5.3. Effect of Citrus Flavonoids, Grape Polyphenols and Phenolic Acids 
The citrus flavonoids, hesperidin and naringin (0.2 g/kg) were shown to lower blood glucose levels 
as compared to the control diet fed to db/db mice [143]. Similarly to green tea and soy, hesperidin and 
naringin also significantly reduced plasma free fatty acid, TG and total cholesterol levels in plasma as 
well as hepatic TG content. These physiological changes were postulated to be due to increase in 
hepatic glucokinase mRNA, decrease in expression of the gluconeogenetic enzymes PEPCK and 
G6Pase, and improvement in lipid metabolism caused by altered activities of hepatic lipid 
metabolizing enzymes [143,144]. Furthermore, naringenin (25–100 µM), the aglycone form of 
naringin, was shown to suppress hepatic glucose production from hepatoma cells in a dose dependent 
manner even though naringenin did not have any impact on gluconeogenetic gene expression [145]. 
However, naringenin exposure led to decrease in cellular ATP levels. 
Grape seed-derived polyphenols such as procyanidins have been also shown to alleviate insulin 
resistance in mice fed with high-fat diet. Simultaneous supplementation of grape-seed derived 
procyanidin-rich extract and G. pentaphyllum extract (altogether 80 mg/kg) improved glucose 
tolerance and HOMA-IR index, as well as lowered the high-fat-diet induced serum glucose levels and 
also increased the activity of hepatic glucokinase [95]. Int. J. Mol. Sci. 2010, 11                 
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Unlike polyphenols discussed above, resveratrol was shown to have opposite effects and increase 
the expression and activity of gluconeogenetic enzymes. As Ganjam et al. [146] showed, rats treated 
with resveratrol (5–10 mg/kg/day) by intraperitoneal injections for 2 days lead to decreased GK 
mRNA levels in liver in a dose-dependent manner. The decreased GK mRNA expression was 
accompanied by a reduction in GK protein levels. In primary rat hepatocyte cultures resveratrol   
(10–50 µM) also suppressed GK expression and conversely enhanced PEPCK expression. The 
suppression of GK by resveratrol was found to be mediated, at least partly, by the deacetylation of 
FoxO1-transcription factor and further binding to HNF-4 (hepatocyte nuclear factor) that can restrain it 
from its binding site in the proximal GK promoter [146]. Similar effects of resveratrol on hepatic 
glucose metabolism have been shown with H4IIE rat hepatoma cells [147]. However, there are 
controversial findings showing that activation of SIRT1 was repressing forkhead transcription factors 
including Foxo1 in different cell models [148]. On the other hand, the results are supported by the fact 
that knockdown of SIRT1 in liver leads to decrease in gluconeogenesis [149]. The roles of Foxos and 
sirtuins in the regulation of hepatic glucose metabolism clearly need further clarification. 
Administration of phenolic acid fraction of rice bran containing considerable amounts of trans-
cinnamic acid derivatives (ferulic acid, and p-coumaric acid) and ferulic acid alone for 17 days was 
shown to exert hypoglycemic effects and to elevate liver glycogen synthesis and glucokinase activity 
in db/db mice compared with the control group [150]. Insulin secretion was also improved, and it was 
postulated that the rice bran fraction and ferulic acid could have increased insulin action and the 
utilization of dietary glucose in the liver. 
In conclusion, several different polyphenol classes have been shown to reduce hepatic glucose 
output by suppressing gluconeogenetic enzyme expression and increasing the activity of glucokinase 
to improve glycogenesis and glucose utilization. EGCG has been shown to exhibit these effects by 
activating AMPK. Furthermore, theaflavins have been shown to activate AMPK in HepG2 cells and to 
attenuate hepatic lipid accumulation [151]. Activation of AMPK by dietary polyphenols leads to 
suppression of hepatic gluconeogenesis and induction of fatty acid β-oxidation that both improve 
hepatic glucose utilization and insulin sensitivity [152]. Resveratrol seems to function in opposite way 
by activating FoxO1 and inducing hepatic gluconeogenesis. In contrast, resveratrol has been also 
shown to activate hepatic AMPK [153,154]. Therefore the role of resveratrol in hepatic glucose 
metabolism needs further clarification. Recent findings suggest that FoxO1 integrates insulin 
signalling with hepatic mitochondrial function and inhibition of Foxo1 can improve hepatic 
metabolism during insulin resistance and the metabolic syndrome [155]. In addition to the changes in 
hepatic glucose utilization and output, most of the in vivo studies report changes in hepatic TG 
contents as well as in blood TG contents. As the hepatic lipid accumulation is connected to insulin 
resistance it is therefore possible that phytochemicals could exert their effects indirectly on hepatic 
glucose output by influencing lipid metabolism. In vivo studies have also reported increased insulin 
secretion or changes in blood insulin levels after polyphenol rich diet and therefore the hepatic effects 
could be also due to insulin signalling.  Int. J. Mol. Sci. 2010, 11                 
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6. Impact of Polyphenols on Maintenance of Glucose Homeostasis  
The majority of the studies on the effects of dietary polyphenols on carbohydrate homeostasis are 
performed by specific assays focusing on certain parts of the regulatory system. There is, however, 
increasing data from long-term dietary studies on polyphenol supplementation in animal models and in 
humans. In such trials, the most common outcome parameters are the blood glucose and insulin levels, 
the measurements of body fat composition and circulating levels of triglycerides, free fatty acids or 
other lipid metabolism related biomarkers such as cholesterol, measurement of inflammatory markers, 
and factors related to the redox status of the organs. The most relevant mechanisms underlying the 
beneficial health effects are, however, difficult to postulate as the molecular mechanisms have not 
been comprehensively studied. 
6.1. Evidence from Epidemiological Studies 
In epidemiological studies, very few of the individual polyphenolic compounds alone have been so 
far demonstrated to have a beneficial effect on prevention of type 2 diabetes. A prospective study of 
flavonoid intake from the Finnish diet concluded that quercetin and myricetin are associated with 
reduced risk of type 2 diabetes [5]. On contrary, intakes of quercetin, kaempferol, myricetin, apigenin, 
and luteolin were not associated with reduced risk of type 2 diabetes in The Women’s Health Study 
[156]. However, the inverse association with diabetes risk in epidemiological studies has been shown 
with whole polyphenol-rich diets/food items, which suggests that the effects of polyphenols on disease 
risk cannot be attributed to single compounds. This is an important issue for consideration for the 
mechanistic studies using in vitro models. Whole grain rich diets have been linked with decreased risk 
of obesity and type 2 diabetes in epidemiological studies [157,158], and high coffee consumption has 
been associated with lower prevalence of metabolic syndrome [19,159]. Apples and tea consumption 
have also been linked to lowered incidence of type 2 diabetes in middle-aged women [156], and apples 
and berries were the most important contributors lowering the risk in Finnish men and women [5]. In a 
meta-analysis including nine cohort studies with follow-up ranging from 5 to 18 years, tea 
consumption was associated with prevention of development of type 2 diabetes [160]. Over four cups 
of tea per day was required to produce the beneficial effect, although also smaller intake has been 
shown to be effective in lowering the risk of obesity and blood glucose levels [161]. These beneficial 
effects by both coffee and tea intakes have been demonstrated also in a recent cohort study where the 
effect of single compounds magnesium, potassium, and caffeine alone was excluded, and it also was 
concluded that the effect was not mediated by blood pressure lowering effect [162]. 
6.2. Evidence from Clinical Trials 
There are only a few controlled interventions studying the effects of specific polyphenols or food 
products in amelioration of the symptoms of the metabolic syndrome. One of the polyphenols studied 
most frequently in vitro is EGCG and/or its source green tea extract. In spite of promising results from 
animal and in vitro testing, EGCG treatment has not been shown to improve insulin resistance in 
humans, although some beneficial health impacts have been observed [163,164]. One study on type 2 
diabetes patients showed increased levels of insulin after 12 weeks of diet supplemented with catechin-Int. J. Mol. Sci. 2010, 11                 
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rich (582.8 mg) green tea [165], and another study revealed correlation between high intake of tea 
polyphenols and improved insulin levels in type 2 diabetes patients [164]. In contrast to tea, interesting 
results have been produced in human trials by dark chocolate consumption. Dark chocolate (100 g dark 
chocolate bar containing approximately 500 mg of polyphenols for 15 days) improved insulin 
sensitivity along with reducing blood pressure in healthy subjects [166] and similar results were 
reported with the same treatment on hypertensive subjects [167]. However, consumption of a flavanol-
rich cocoa drink (150 mL twice a day, approximately 900 mg flavanols) for 15 days did not improve 
insulin resistance or blood pressure in individuals with essential hypertension [168]. Grape seed 
extract given to type 2 diabetic patients for 4 weeks, had positive effect on several inflammatory 
markers and glycaemia, but did not result in statistically significant changes in HOMA-IR [169]. In 
regard of whole grain consumption the beneficial health effects may also be, at least partly, due to the 
polyphenol content of whole grain products, as a polyphenol-rich wheat bread had higher glucose 
lowering and antioxidative effect than a control wheat bread during a 9-day study period [170]. Other 
promising plant food candidates with diabetes preventive potential include cinnamon, bitter melon and 
fenugreek [171]. 
6.3. Evidence from Animal Experiments  
On the other hand, considerable evidence is available on the effects of several polyphenols and 
polyphenol-rich food items in ameliorating insulin resistance and improving insulin sensitivity in 
experimental animals. In mice fed high-fat diet indications towards beneficial effect in glucose/insulin 
signaling have been obtained by catechin [172], EGCG [134], grape seed procyanidins [173], and 
blueberry [174]. Similarly in rats fed high-fat diet isoflavones [175], quercetin [176], and blueberry 
[177] have alleviated the markers of metabolic syndrome. Another type of high-calorie diet, fructose-
rich diet, has been applied in rat experiments, producing promising results in balancing the 
glucose/insulin metabolism with myricetin [178], fenugreek seed extract or quercetin [179], longan 
flower extract [180], green tea [181] and cinnamon [119,179]. Moreover, insulin sensitivity was 
improved in the CD-1 mice that have genetic susceptibility to obesity and type 2 diabetes by feeding a 
diet containing soy [140]. 
In conclusion, the evidence from epidemiological studies on the protective role of polyphenol-rich 
foods against development of type 2 diabetes is suggestive, but in spite of the large array of studies in 
vitro and the positive results in animal models, only a handful of controlled human interventions 
confirm these results. The discrepancy between the results from animal and human studies may be due 
to species specific differences, but also other factors such as genetic variability and general study set-
up (dosage of supplementation, number of study objects, length of intervention) most likely have an 
impact on the outcome. It is clear that more tightly controlled human studies should be conducted in 
order to draw conclusions about the role of polyphenols in insulin resistance. 
7. Conclusions and Future Prospects 
Foods or meals high in available carbohydrate such as starch or sucrose induce hyperglycemia and 
hyperinsulinemia. Regular consumption of diets with high glycemic impact may increase the risk of 
obesity, type 2 diabetes and cardiovascular disease by promoting excessive food intake, pancreatic  Int. J. Mol. Sci. 2010, 11                 
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-cell dysfunction, dyslipidemia, and endothelial dysfunction [27]. The potential of polyphenols in 
controlling glycemia is a very intensively studied area, encompassing a large piece of scientific 
literature; studies listed in PubMed in this field in 2009 alone gave over 70 hits. Indications for 
positive effects of a large number of polyphenols on glucose homeostasis have been obtained in vitro 
and in animal studies, but definitive conclusions, especially from controlled human studies and at the 
molecular mechanistic level have not been obtained. There is a shortage of human studies with 
clinically relevant end-points indicating effects during postprandial handling of dietary carbohydrates, 
pancreatic insulin secretion and its functions on glucose homeostasis in peripheral tissues. 
The field is broad because carbohydrate metabolism constitutes one of the most important 
physiological functions in the human body involving numerous different organs, tissues and cell types. 
On the other hand, the amount of dietary constituents potentially contributing to glucose homeostasis 
is vast, and especially for bioactive non-nutrients, such as polyphenols, mostly unidentified. One 
important issue in research on dietary phytochemicals is the lack of knowledge on their absorption, 
metabolite composition and tissue distribution. Plants contain thousands of metabolites in different 
quantitative and qualitative combinations, and the identification of combinations of active molecules in 
a given metabolic pathway is an extremely challenging task.  
The studies performed in cell cultures with single plant phenolic compounds at concentrations 
exceeding pharmacological doses do not have much predictive value of the effects these compounds 
would produce when fed in diet and harnessing their target tissues after the metabolism of gut 
microbiota and the human organs. It is therefore understandable that data from controlled human 
interventions is missing or contradictory in spite of the positive epidemiological evidence with e.g., 
whole grains, apples, tea and coffee, and studies with pure compounds and extracts showing effects in 
various steps of glucose metabolism in cell and animal models. However, in comparison to the studies 
reported a decade ago, the current in vitro studies tend to use amounts of phenolic compounds closer to 
the range of physiological levels than pharmacological doses.  
It is obvious that more human trials with well defined diets and controlled study set-ups should be 
made to test the hypotheses created by the mechanistic studies, and early biomarkers are needed to 
reveal the effects of subtle dietary changes in intervention studies. Dose response studies and 
pharmacokinetic profiling of the hypothetic active metabolites should also be made. More focus should 
be laid on the studies analysing the effect of whole plant/food extracts in order to follow the 
synergistic bioactivity of the different phytochemical compounds present in the food concomitantly. 
Also the interplay between the phenolic compounds and other food constituents such as fibre, is an 
interesting topic that undoubtedly deserves attention in the case of food products that are rich in both 
polyphenols and fibre, including whole grain products and fruits like apple.  
The research on health effects of plant-based foods will benefit from taking holistic approaches 
with the aim to resolve an array of effects mediated by an array of bioactive metabolites on the whole 
body level. One of the key factors will be the combination of the different omics-profiling techniques 
in the concept of systems biology, or nutrigenomics as termed in the context of nutrition related 
sciences. Whilst transcriptomics and proteomics characterization are already available on relatively 
routine laboratory analyses, metabolomics analyses are also rapidly developing, and are expected to be 
an even more useful tool in making the link between food constituents and subsequent clinical 
outcome, also in diabetes related research [182]. Especially the non-targeted profiling assays where the Int. J. Mol. Sci. 2010, 11                 
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metabolite pools of control group and test group (e.g., after dietary challenge) are compared and the 
metabolite signals significantly differing are resolved with statistical analysis methods. In the 
elucidation of the effects of dietary phytochemicals on human health, such analyses will likely play a 
key role in pointing out the factors from bioavailability, absorption, microbial metabolism, whole body 
distribution, tissue localization and mechanisms of action that would not be achievable by targeted 
single compound assays.  
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Main conclusions 
  There are indications for positive effects on glucose homeostasis with 
polyphenols and polyphenol-rich plant extracts from in vitro & animal 
studies. 
  Epidemiological evidence supports beneficial effects of polyphenol- rich 
diets.  
  Clinical studies so far have not undoubtedly succeeded in pointing out 
any specific polyphenols or food products in reducing the risk of insulin 
resistance.  
  It is evident that in clinical studies whole diets instead of single 
compounds or food components should be addressed. 
  Combination of specific clinical measurements determining glucose 
tolerance and insulin sensitivity together with systems biology profiling 
technologies is needed to get a holistic view on the health effects of diets 
and foods rich in polyphenols. Int. J. Mol. Sci. 2010, 11                 
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